Labuda, S. M. et al. Rates of Hospitalization and Infection-Related Hospitalization Among Human Immunodeficiency Virus (HIV)-Exposed Uninfected Children Compared to HIV-Unexposed Uninfected Children in the United States, 2007-2016. Clin. Infect. Dis. 71, 332–339 (2020).
Epalza, C. et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 126, e631–e638 (2010).
Paul, M. E. et al. Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study. Pediatr. Infect. Dis. J. 24, 46–56 (2005).
Kuhn, L. et al. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin. Infect. Dis. 50, 437–444 (2010).
Marinda, E. et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr. Infect. Dis. J. 26, 519–526 (2007).
Arikawa, S., Rollins, N., Newell, M. L. & Becquet, R. Mortality risk and associated factors in HIV-exposed, uninfected children. Trop. Med Int Health 21, 720–734 (2016).
Prendergast, A. J. & Evans, C. Children who are HIV-exposed and uninfected: evidence for action. AIDS 37, 205–215 (2023).
McNally, L. M. et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 369, 1440–1451 (2007).
Hunt, P. W. HIV and inflammation: mechanisms and consequences. Curr. HIV/AIDS Rep. 9, 139–147 (2012).
Akoto, C., Norris, S. A. & Hemelaar, J. Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women. Sci. Rep. 11, 10079 (2021).
Dirajlal-Fargo, S. et al. HIV-exposed-uninfected infants have increased inflammation and monocyte activation. AIDS 33, 845–853 (2019).
Schnittman, S. R. et al. Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection. Open Forum Infect. Dis. 8, ofab245 (2021).
Shiau, S. et al. Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected. J. Neurovirol. 27, 702–715 (2021).
Vyas, P. et al. Impact of HIV status on systemic inflammation during pregnancy. AIDS 35, 2259–2268 (2021).
Jalbert, E. et al. Impaired functionality of antigen presenting cells in HIV- exposed uninfected infants in the first six months of life. Front. Immunol. 13, 960313 (2022).
Jalbert, E. et al. HIV-exposed uninfected infants have increased regulatory T cells that correlate with decreased T cell function. Front. Immunol. 10, 595 (2019).
Reikie, B. A. et al. Altered innate immune development in HIV-exposed uninfected infants. J. Acquir Immune Defic. Syndr. 66, 245–255 (2014).
Yin, L. et al. Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants. Front. Immunol. 15, 1443886 (2024).
Egorova, M., Egorov, V. & Zabrodskaya, Y. Maternal Influenza and Offspring Neurodevelopment. Curr. Issues Mol. Biol. 46, 355–366 (2024).
Elgueta, D., Murgas, P., Riquelme, E., Yang, G. & Cancino, G. I. Consequences of Viral infection and cytokine production during pregnancy on brain development in offspring. Front Immunol. 13, 816619 (2022).
Estes, M. L. & McAllister, A. K. Maternal immune activation: Implications for neuropsychiatric disorders. Science 353, 772–777 (2016).
Han, V. X. et al. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Transl. Psychiatry 11, 71 (2021).
Knuesel, I. et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat. Rev. Neurol. 10, 643–660 (2014).
Mednick, S. A., Machon, R. A., Huttunen, M. O. & Bonett, D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45, 189–192 (1988).
Fernandes, K. A. & Lim, A. I. Maternal-driven immune education in offspring. Immunol. Rev. 323, 288–302 (2024).
Hofsink, N., Groenink, L. & Plosch, T. The fetal programming effect of maternal immune activation (MIA) on the offspring’s immune system. Semin. Immunopathol. 46, 14 (2024).
Lim A. I. et al. Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science. 373, https://doi.org/10.1126/science.abf3002 (2021).
Byakwaga, H. et al. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. J. Infect. Dis. 210, 383–391 (2014).
Favre, D. et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2, 32ra36 (2010).
Cao, B. et al. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis. Neurosci. Biobehav Rev. 123, 203–214 (2021).
Mehraj, V. & Routy, J. P. Tryptophan catabolism in chronic viral infections: handling uninvited guests. Int J. Tryptophan. Res. 8, 41–48 (2015).
Seo, S. K. & Kwon, B. Immune regulation through tryptophan metabolism. Exp. Mol. Med. 55, 1371–1379 (2023).
Pedraz-Petrozzi, B. et al. LC-MS/MS-based quantification of tryptophan, kynurenine, and kynurenic acid in human placental, fetal membranes, and umbilical cord samples. Sci. Rep. 13, 12554 (2023).
Huengsberg, M. et al. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin. Chem. 44, 858–862 (1998).
Hunt, P. W. et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 210, 1228–1238 (2014).
Wada, N. I. et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 29, 463–471 (2015).
Vujkovic-Cvijin, I. et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5, 193ra91 (2013).
Gazi, M. A. et al. Plasma Kynurenine to Tryptophan ratio is negatively associated with linear growth of children living in a slum of bangladesh: results from a community-based intervention study. Am. J. Trop. Med. Hyg. 104, 766–773 (2020).
Kosek, M. N. et al. Plasma Tryptophan and the Kynurenine-Tryptophan ratio are associated with the acquisition of statural growth deficits and oral vaccine underperformance in populations with environmental enteropathy. Am. J. Trop. Med Hyg. 95, 928–937 (2016).
Fazzolari-Nesci, A., Domianello, D., Sotera, V. & Raiha, N. C. Tryptophan fortification of adapted formula increases plasma tryptophan concentrations to levels not different from those found in breast-fed infants. J. Pediatr. Gastroenterol. Nutr. 14, 456–459 (1992).
Kamimura, S., Eguchi, K. & Sekiba, K. Tryptophan and its metabolite concentrations in human plasma and breast milk during the perinatal period. Acta Med Okayama 45, 101–106 (1991).
O’Rourke, L. et al. Tryptophan metabolic profile in term and preterm breast milk: implications for health. J. Nutr. Sci. 7, e13 (2018).
van Sadelhoff J. H. J. et al. Short communication: differences in levels of free amino acids and total protein in human foremilk and Hindmilk. Nutrients. 10, https://doi.org/10.3390/nu10121828 (2018).
Zanardo, V., Bacolla, G., Biasiolo, M. & Allegri, G. Free and bound tryptophan in human milk during early lactation. Biol. Neonate 56, 57–59 (1989).
Gizzi, A. S. et al. A naturally occurring antiviral ribonucleotide encoded by the human genome. Nature 558, 610–614 (2018).
Kuhn, L. et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N. Engl. J. Med. 359, 130–141 (2008).
Wong, A. C. et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 186, 4851–4867 e20 (2023).
Bender, J. M. et al. Maternal HIV infection influences the microbiome of HIV-uninfected infants. Sci. Transl. Med. 8, 349ra100 (2016).
Almulla, A. F. et al. The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis. BMC Infect. Dis. 22, 615 (2022).
Rothhammer, V. & Quintana, F. J. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat. Rev. Immunol. 19, 184–197 (2019).
Nunzi E. et al. Host-microbe serotonin metabolism. Trends Endocrinol. Metab. https://doi.org/10.1016/j.tem.2024.07.014. (2024).
Kandanearatchi, A. & Brew, B. J. The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders. FEBS J. 279, 1366–1374 (2012).
Mehta, R. et al. Antiviral metabolite 3’-deoxy-3’,4’-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19. Med. 3, 204–215.e6 (2022).
Sala, S. et al. Integrative molecular structure elucidation and construction of an extended metabolic pathway associated with an ancient innate immune response in COVID-19 patients. J. Proteome Res.23,956–970 (2024).
Helbig, K. J. & Beard, M. R. The role of viperin in the innate antiviral response. J. Mol. Biol. 426, 1210–1219 (2014).
Seo, J. Y., Yaneva, R. & Cresswell, P. Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe 10, 534–539 (2011).
Nasr, N. et al. HIV-1 infection of human macrophages directly induces viperin, which inhibits viral production. Blood 120, 778–788 (2012).
Blasco, H. et al. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Sci. Rep. 10, 16824 (2020).
Danchin, A. & Marliere, P. Cytosine drives evolution of SARS-CoV-2. Environ. Microbiol. 22, 1977–1985 (2020).
Metz, P. J. et al. Symmetric Arginine Dimethylation is selectively required for mRNA splicing and the initiation of Type I and Type III Interferon signaling. Cell Rep. 30, 1935–1950.e8 (2020).
Tobin, N. H. et al. Maternal HIV infection and the milk microbiome. Microbiome 12, 182 (2024).
Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M. & Milgram, E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal. Chem. 81, 6656–6667 (2009).
Ford, L. et al. Precision of a clinical metabolomics profiling platform for use in the identification of inborn errors of metabolism. J. Appl. Lab. Med. 5, 342–356 (2020).
Evans, A. M., Bridgewater, B. R. & Liu, Q. High Resolution Mass Spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics. Metabolomics 4, 132 (2014).
Li F. BMM. GitHub. https://github.com/fanli-gcb/BMM, https://doi.org/10.5281/zenodo.16658314.
